IMUGENE CHART. TA only, page-30893

Princess Kate's diagnosis, along with the previous diagnosis for King Charles will see a huge benefit for cancer sufferers worldwide as the focus shifts to early diagnosis methods and, following diagnosis the development of targeted treatments in all forms of cancer including solid tumours.
Imugene could not be better placed to be one of the pioneers in the solid tumours space with CF33 + Azer-cel which as previously mentioned has shown outstanding preclinical results.
The diagnosis of these members of the Royal Family will also see a rush of investors both institutional and retail to the biotechnology market.
We would all wish both families the best and it appears they would both have a promising prognosis, given the available information on the news.
Remembering that they would both be receiving the absolute best medical advice and treatment, this is not always the case as can be seen in third world countries where prognosis is much poorer due to lack of available medical needs.
Yuman Fong and Leslie Chong's vision is to make their treatment far cheaper and more widely available to the greater world, let's hope their vision becomes a reality.

DYOR opinion only